Market header image

Bulletins

You are here

2016-0819 - Suspension - Pivotal Therapeutics Inc. (PVO)

August 17, 2016

Pivotal Therapeutics Inc. is in default of CSE requirements. Effective at market close, Pivotal Therapeutics, currently the subject of a Cease Trade Order, will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

Date: Effective market close, August 17, 2016
Symbol: PVO

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

11_28_CanEx_Cannabis_Investment_Summit_Website

CanEx Cannabis Investment Summit

Thursday, November 28, 2019 -
9:00am to 6:00pm
12_08_Arcview_Las_Vegas_Website

Arcview Cannabis Investor Forum in Las Vegas

Sunday, December 8, 2019 (All day) to Tuesday, December 10, 2019 (All day)
12_10_14th_MA_Forum_Montreal_Website

14th M&A Forum Montréal

Tuesday, December 10, 2019 -
7:00am to 7:00pm

Advertisement

Publicité